NIMH Code: | B-918 |
Compound Name: | 1,3-Bis(8-acetyleno-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine-3-carboxy)propyl diester |
Alternative Name: | XLi-093 |
Abbreviation: | Bis[8-ethynyl-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid] 1,3-propanediyl ester |
PubChemID: | 131701296 |
CAS: | 646066-59-3 |
Molecular Formula: | C33H26N6O6 |
Biological Activity: | Selective alpha5 GABA-A receptor antagonist/negative allosteric modulator |
References: | Li, X.; Cao, H.; Zhang, C.; Furtmüeller, R.; Fuchs, K.; Huck, S.; Sieghart, W.; Deschamps, J.; Cook, J. M., J. Med. Chem. 2003, 46, 5567-5570. Savic, M.; Milinkovic, M.; Rallapalli, S.; Clayton, T. Sr.; Joksimovic, S.; Van Linn, M.; Cook, J., Neuropsychopharmacology 2009, 12, 1179-1193. Xu, N.Z.; Ernst, M.; Treven, M.; Cerne, R.; Wakulchik, M.; Li, X.; Jones, T.M.; Gleason, S.D.; Morrow, D.; Schkeryantz, J.M.; Rahman, M.T.; Li, G.; Poe, M.M.; Cook, J.M.; Witkin, J.M., Psychopharmacology, 2018, 235, 1151-1161. |
Comments: | Note the structure in PubChem may not be correct |
Last Updated 2021-02-17 11:37 AM |
Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.